AstraZeneca is one of the world's leading pharmaceutical companies, dedicated to the discovery, development, manufacturing and marketing of high quality, effective prescription medicines that bring benefit for patients.
We discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. We also focus on getting the best from every medicine we make by exploring all the ways it can be used or improved.
SEROQUEL
SEROQUEL has been approved for the treatment of schizophrenia since 1997 and for mania associated with bipolar disorder since 2003. SEROQUEL is available in over 80 countries worldwide, including the US and across Europe. In October 2006 the U.S. Food and Drug Administration (FDA) approved SEROQUEL for the treatment of patients with depressive episodes associated with bipolar disorder. SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder.